New oral test could replace painful insulin injection for hormone deficiency diagnosis
NCT ID NCT07259564
First seen Jan 05, 2026 · Last updated Apr 30, 2026 · Updated 21 times
Summary
This study tests a new oral drug (GS3-007a) to see if it can accurately diagnose adult growth hormone deficiency (AGHD). It compares the new test to the standard insulin tolerance test. About 120 adults suspected of having AGHD, plus some healthy volunteers, will take part. The goal is to find a simpler, more comfortable way to diagnose this condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT GROWTH HORMONE DEFICIENCY (AGHD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
Conditions
Explore the condition pages connected to this study.